Literature DB >> 15156190

Tumor suppressor activity of RUNX3.

Suk-Chul Bae1, Joong-Kook Choi.   

Abstract

Recent analyses have revealed that RUNX family members play important roles in both normal developmental processes and carcinogenesis. Of the three known RUNX family members, RUNX3 has been shown to be involved in neurogenesis of the dorsal root ganglia, T-cell differentiation and tumorigenesis of gastric epithelium. Deletion of the Runx3 locus in mice resulted in hyperplasia of the gastric epithelium due to the stimulation of proliferation and suppression of apoptosis that was accompanied by a reduced sensitivity to TGF-beta1. In primary human gastric cancer specimens, RUNX3 is frequently inactivated by allele loss or gene silencing due to promoter hypermethylation. The tumorigenicity of human gastric cancer cell lines in nude mice decreased as the level of RUNX3 expression increased, which indicates that RUNX3 is a bona fide tumor suppressor of gastric cancers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15156190     DOI: 10.1038/sj.onc.1207286

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3.

Authors:  Kyoung Ah Kang; Rui Zhang; Gi Young Kim; Suk Chul Bae; Jin Won Hyun
Journal:  Tumour Biol       Date:  2012-01-25

2.  RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.

Authors:  Martin C Whittle; Kamel Izeradjene; P Geetha Rani; Libing Feng; Markus A Carlson; Kathleen E DelGiorno; Laura D Wood; Michael Goggins; Ralph H Hruban; Amy E Chang; Philamer Calses; Shelley M Thorsen; Sunil R Hingorani
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

3.  DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.

Authors:  Han Han; Connie C Cortez; Xiaojing Yang; Peter W Nichols; Peter A Jones; Gangning Liang
Journal:  Hum Mol Genet       Date:  2011-08-11       Impact factor: 6.150

4.  Crlz-1 is prominently expressed in spermatogonia and Sertoli cells during early testis development and in spermatids during late spermatogenesis.

Authors:  Jung-Hyun Lim; Seong-Young Choi; Han-Woong Yoo; Sun-Jung Cho; Youngsook Son; Chang-Joong Kang
Journal:  J Histochem Cytochem       Date:  2013-03-22       Impact factor: 2.479

5.  Methylation of the Tumor Suppressor Gene RUNX3 in Human Gastric Carcinoma.

Authors:  Hyun Joo Song; Ki-Nam Shim; Yang-Hee Joo; Seong-Eun Kim; Sung-Ae Jung; Kwon Yoo
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

Review 6.  DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

Authors:  Yuji Toiyama; Yoshinaga Okugawa; Ajay Goel
Journal:  Biochem Biophys Res Commun       Date:  2014-08-13       Impact factor: 3.575

7.  Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer.

Authors:  Gui-Ping Yu; Yong Ji; Guo-Qiang Chen; Bin Huang; Kai Shen; Song Wu; Zhen-Ya Shen
Journal:  Oncol Lett       Date:  2011-10-19       Impact factor: 2.967

8.  Placental DNA methylation alterations associated with maternal tobacco smoking at the RUNX3 gene are also associated with gestational age.

Authors:  Jennifer Z J Maccani; Devin C Koestler; Eugene Andrés Houseman; Carmen J Marsit; Karl T Kelsey
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

9.  Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia.

Authors:  Adrian Krygier; Dagmara Szmajda; Marta Żebrowska; Agnieszka Jeleń; Ewa Balcerczak
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

10.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.